Registering for more than one person? A TMA login is required for each person you register. Need help? Contact the TMA Knowledge Center at (800) 880-7955.
You must select a location to proceed.
Yes
No
There was a problem adding this course to your account. Please try again in a few minutes. If the problem persists, you can contact our support department at (877) 880-1335.
This program is eligible to count towards federal and/or state mandated trainings.*
Urine drug testing is an essential tool in managing patients with chronic pain, but not all tests are created equal. Andre Chen, MD, an addiction medicine specialist, breaks down the difference between the two principal types of urine drug tests.
Best Bits
Overview of Centers for Disease Control and Prevention guidelines and Texas Medical Board minimum requirements
Urine drug screen vs. urine drug test
Why you should test and things to consider when testing
Learning Objectives Upon completion of this program, participants should be able to:
Discuss the rationale for urine drug testing in pain management;
Review implementation considerations for urine drug testing;
Explore the two principal types of urine drug tests and their specific uses and limitations;
Examine the process of interpreting urine drug test results including common pitfalls; and
Review consensus recommendations regarding the frequency and scope of testing including individual risk assessment.
ACGME/ABMS Competencies This program addresses the following desirable physician attributes: provide patient-centered care, interpersonal and communication skills, professionalism, systems-based practice, and roles/responsibilities.
*Meeting Mandated CME Requirements This program is eligible to count towards: (i) the eight hours of training on treatment and management of patients with opioid or other substance use disorders required for all U.S. Drug Enforcement Administration-registered practitioners, and (ii) the two hours of CME in the study of pain management and the prescribing and monitoring of controlled substances required by the Texas Medical Board.
This program will address the TMB specified topics of:
Safe and effective pain management related to the prescription of opioids and other controlled substances, including education regarding:
Identification of drug-seeking behavior in patients; and
Participation in this program in no way implies the participant has fully met the federally and state-mandated training requirements. Participants are solely responsible for ensuring any mandated training requirements are completed.
Return Policy No refunds or exchanges will be processed for this program.
0.75 AMA PRA Category 1 Credits™ (Enduring) The Texas Medical Association is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The Texas Medical Association designates this enduring activity for a maximum of 0.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
On select courses, the Texas Medical Association requires physician to complete 70-percent of the test questions correctly to receive credit for this course.
0.75 ETHICS This course has been designated for 0.75 credit(s) of education in medical ethics and/or professional responsibility.
0.75 DEA SUD The Consolidated Appropriations Act of 2023 enacted a new one-time, eight-hour training requirement for all Drug Enforcement Administration (DEA)-registered practitioners on the treatment and management of patients with opioid or other substance use disorders. This program is eligible to count towards the training requirement. Participation in this program in no way implies the participant has fully met the federally and state-mandated training requirements. Participants are solely responsible for ensuring any mandated training requirements are completed.
0.75 Opioid This program is eligible to count towards the two hours of CME in the study of pain management and the prescribing and monitoring of controlled substances required by the Texas Medical Board. See the program description for the specific topics identified by the TMB that this program addresses. Participation in this program in no way implies the participant has fully met the federally and state-mandated training requirements. Participants are solely responsible for ensuring any mandated training requirements are completed.
Customers Who Bought This Item Also Bought
(On Demand Webinar) Multimodal Opioid-Sparing Strategies for Acute Pain Management
(On Demand Webinar) Amphetamines, the Next Epidemic: What History Has Not Taught Us
(On Demand Webinar) Addiction in Chronic Pain Patients: How to Know and What to Do
(On Demand Webinar) Red Flag Behaviors in Pain Management
(On Demand Webinar) Buprenorphine for Pain and Opioid Use Disorders
(On Demand Webinar) Screening, Brief Intervention, and Referral to Treatment of Substance Use Disorders (SBIRT)
(CME to Go/Podcast) Opioid Stewardship
(On Demand Webinar) Healthy Conversations: Engaging with Your Patient about Substance Use Disorders
(On Demand Webinar) Shades of Grey
(On Demand Webinar) Management of Chronic Pain Patients with Substance Use Disorders
(On Demand Webinar) Change in Approach to Opioids
(On Demand Webinar) Meeting TMB Education Requirements for Opioid Prescribing
Adding Registration, Please wait...
